Search Results - "Siu CO"

Placebo versus no treatment for people with schizophrenia: A systematic review and meta‐analysis.

Authors: Nomura, Nobuyuki Shimomura, Yutaro Kikuchi, Yuhei et al.

Source: Psychiatry & Clinical Neurosciences Reports. Dec2025, Vol. 4 Issue 4, p1-3. 3p.

Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them.

Authors: Howes OD Bukala BR Chen EYH et al.

Source: The American journal of psychiatry [Am J Psychiatry] 2025 Nov 01; Vol. 182 (11), pp. 969-983. Date of Electronic Publication: 2025 Oct 08.

Publication Type: Journal Article; Systematic Review

Journal Info: Publisher: American Psychiatric Association Country of Publication: United States NLM ID: 0370512 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-7228 (Electronic) Linking ISSN: 0002953X NLM ISO Abbreviation: Am J Psychiatry Subsets: MEDLINE

2023 ANZUP Annual Scientific Meeting, 9‐11 July 2023, Melbourne Convention Centre, Victoria, Australia.

Source: Asia Pacific Journal of Clinical Oncology. Jul2023 Supplement 1, Vol. 19, p1-112. 112p.

The impacts of antipsychotic medications on eating-related outcomes: A mixed methods systematic review.

Authors: Alkholy, Rasha Lovell, Karina Bee, Penny et al.

Source: PLoS ONE. 2/3/2025, Vol. 20 Issue 1, p1-36. 36p.

Immunoinflammatory features and cognitive function in treatment-resistant schizophrenia: unraveling distinct patterns in clozapine-resistant patients.

Authors: Li, Yanzhe Zhu, Minghuan Dong, Yeqing et al.

Source: European Archives of Psychiatry & Clinical Neuroscience. Aug2025, Vol. 275 Issue 5, p1391-1401. 11p.

Subjects: Schizophrenia, Inflammatory mediators, Immunology of inflammation, Cognition disorders, Cognitive ability

Exploring the Impact of Schizophrenia and Its Pharmacological Treatment on Health-Related Quality of Life and Treatment Preferences.

Authors: Arango, Celso Baeza, Inmaculada García-Rizo, Clemente et al.

Source: Patient Preference & Adherence. Aug2025, Vol. 19, p2647-2661. 15p.

Detailed statistical analysis plan for a guided self-determination intervention versus an attention control for outpatients with type 2 diabetes in the randomised OVERCOME trial.

Authors: Mathiesen, Anne Sophie Zoffmann, Vibeke Lindschou, Jane et al.

Source: Trials. 11/11/2024, Vol. 25 Issue 1, p1-7. 7p.

Abstracts Index.

Source: Value in Health. May2003, Vol. 6 Issue 3, p393-401. 9p.

Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort.

Authors: Fond, G. Godin, O. Boyer, L. et al.

Source: European Archives of Psychiatry & Clinical Neuroscience. Dec2019, Vol. 269 Issue 8, p985-992. 8p. 1 Chart, 1 Graph.

Subjects: Schizophrenia, Inflammation, Antipsychotic agents, Tobacco smoke, Metabolic syndrome

CLEAR – clozapine in early psychosis: study protocol for a multi-centre, randomised controlled trial of clozapine vs other antipsychotics for young people with treatment resistant schizophrenia in real world settings.

Authors: Casetta, C. Santosh, P. Bayley, R. et al.

Source: BMC Psychiatry. 2/14/2024, Vol. 24 Issue 1, p1-13. 13p.

Predictors of response to family-based treatment for anorexia nervosa in youth: insights from the VIBUS project.

Authors: Bentz, Mette Pedersen, Signe Holm Moslet, Ulla et al.

Source: European Child & Adolescent Psychiatry. Nov2025, Vol. 34 Issue 11, p3665-3684. 20p.

Family-based cognitive behavioural therapy versus family-based relaxation therapy for obsessive-compulsive disorder in children and adolescents (the TECTO trial): a statistical analysis plan for the randomised clinical trial.

Authors: Olsen, Markus Harboe Hagstrøm, Julie Lønfeldt, Nicole Nadine et al.

Source: Trials. 10/6/2022, Vol. 23 Issue 1, p1-11. 11p. 2 Charts, 3 Graphs.

Clinical Patterns of Dyslipidemia in Patients With Initial-Treatment and Drug-Naïve Schizophrenia.

Authors: Zhaopeng Kang Lin Zhang Tao Jiang et al.

Source: Alpha Psychiatry. Aug2025, Vol. 26 Issue 4, p1-9. 9p.

A network meta-analysis of efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia.

Authors: Dong, Shimeng Schneider-Thoma, Johannes Bighelli, Irene et al.

Source: European Archives of Psychiatry & Clinical Neuroscience. Jun2024, Vol. 274 Issue 4, p917-928. 12p.

Subjects: Antipsychotic agents, Schizophrenia, Clozapine, Weight gain, Olanzapine

Left ventricular and atrial myocardial strain in heart failure with preserved ejection fraction: the evidence so far and prospects for phenotyping strategy.

Authors: Shinzato, Mariane Higa Santos, Natasha Nishida, Gustavo et al.

Source: Cardiovascular Ultrasound. 3/4/2024, Vol. 22 Issue 1, p1-9. 9p.

Novogratz's Galaxy Tokenizes a 316-Year-Old Violin to Back Loan.

Authors: Basak, Sonali (AUTHOR)

Source: Bloomberg.com. 6/3/2024, pN.PAG-N.PAG. 1p.

Depression severity and efficacy outcomes: post hoc analyses from a phase 3 trial of esmethadone for the adjunctive treatment of major depressive disorder with inadequate response to standard antidepressants.

Authors: Guidetti C Papakostas GI Stahl S et al.

Source: International clinical psychopharmacology [Int Clin Psychopharmacol] 2026 Jul 01; Vol. 41 (4), pp. 213-224. Date of Electronic Publication: 2026 Feb 17.

Publication Type: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial

Journal Info: Publisher: Lippincott Williams And Wilkins Country of Publication: England NLM ID: 8609061 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5857 (Electronic) Linking ISSN: 02681315 NLM ISO Abbreviation: Int Clin Psychopharmacol Subsets: MEDLINE

Changes in leukocyte telomere length among children with obesity participating in a behavioural weight control program.

Authors: Rehkopf, David H. Wojcicki, Janet M. Haydel, K. Farish et al.

Source: Pediatric Obesity. Dec2023, Vol. 18 Issue 12, p1-7. 7p.

Altcoin giant Animoca Brands aims to go public next year, listing will test investor appetite for exotic crypto assets.

Authors: Garcia, Carlos (AUTHOR)

Source: Fortune.com. 11/5/2025, pN.PAG-N.PAG. 1p.

Crypto Elite Shun NFTs for 69-Million-Year-Old Dinosaur Fossils.

Authors: Ghosh, Suvashree (AUTHOR)

Source: Bloomberg.com. 12/10/2025, pN.PAG-N.PAG. 1p.